Medication info
Zadiglimet Tablet 12.5/850 mg (Empagliflozin 2L-Proline, Metformin)

Zadiglimet Tablet 12.5/850 mg (Empagliflozin 2L-Proline, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin 2L-Proline›18.9mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
White film-coated tablets that are oval and biconvex with a pink hue
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202503038 · Approved 2025.11.21

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current metformin dose. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions in Precautions for Use). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see item 1) under section 3. Administer with caution to the following patients in Precautions for Use). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see item 2) under section 2. Do not administer to the following patients in Precautions for Use). Older adults In patients aged 75 years and older, consider renal function and the risk of volume depletion.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

View approved original text

This medicine effectively improves blood sugar control in adults with type 2 diabetes by combining empagliflozin and metformin, assisting dietary and exercise regimens. It is particularly suitable for those whose blood sugar is not sufficiently controlled and can also be used with caution in patients with cardiovascular diseases. This medication plays a crucial role in managing diabetes and controlling blood sugar levels.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current metformin dose. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions in Precautions for Use). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see item 1) under section 3. Administer with caution to the following patients in Precautions for Use). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see item 2) under section 2. Do not administer to the following patients in Precautions for Use). Older adults In patients aged 75 years and older, consider renal function and the risk of volume depletion.

Precautions

This medicine is used to treat diabetes and helps lower blood sugar levels. However, rare side effects such as severe lactic acidosis may occur, which is very dangerous and requires immediate treatment. Additionally, caution is advised as hypoglycemia may occur when taken with insulin or sulfonylureas. This medicine should not be administered to certain patients, particularly those with moderate to severe renal impairment, acute infections or dehydration, type 1 diabetes, acute or unstable heart failure, women who are pregnant or nursing, etc. Patients with slightly decreased kidney function or who are at risk of fluid loss should use this medicine cautiously and undergo regular kidney function tests. Furthermore, dose adjustments may be necessary when taken concomitantly with insulin or insulin secretagogues to reduce the risk of hypoglycemia. While taking this medication, side effects such as hypoglycemia, urinary tract infections, genital infections, increased urination, nausea, diarrhea, abdominal pain, decreased appetite, constipation, abnormal liver function tests, hepatitis, altered taste, itching, rash, erythema, headache, dizziness, orthostatic dizziness, drowsiness, thirst, increased serum lipids, elevated hematocrit, decreased and deficiency of Vitamin B12, weight loss, insomnia, vulvar pruritus, genital pruritus, chest discomfort, chest pain, weakness, facial symptoms, etc., may occur. Lactic acidosis may present with symptoms such as vomiting, abdominal pain, difficulty breathing, and weakness, so if these symptoms appear, consult a doctor immediately. Furthermore, care should be taken to prevent dehydration in states at risk of fluid loss, and medication may be temporarily discontinued if necessary. This medicine should be avoided in individuals with poor liver function or those who consume excessive alcohol and should be temporarily discontinued around the time of surgery or iodinated contrast examinations. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medicine for safety. Elderly patients should undergo renal function testing before administration due to the risk of decreased kidney function and be monitored regularly, and it is recommended not to use the maximum dosage. In cases of overdose, serious side effects such as lactic acidosis may occur, requiring immediate hospital treatment and possibly blood dialysis. This medicine is not recommended for children as its safety and efficacy have not been established.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • reduced vitamin B12 and deficiency
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • nausea
  • vomiting
Show 165 more
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • taste disturbance
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • perineal necrosis
  • chronic gastritis
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • urosepsis
  • pyelonephritis
  • vascular stent stenosis
  • vascular stent thrombosis
  • constipation
  • gastritis
  • abdominal discomfort
  • anal incontinence
  • dry mouth
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • headache
  • sensory loss
  • positional dizziness
  • dizziness
  • drowsiness
  • weakness
  • chest discomfort
  • chest pain
  • fatigue
  • peripheral edema
  • facial edema
  • fever
  • facial swelling
  • chills
  • strange sensations
  • edema
  • pain
  • puncture site pain
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight loss
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • Helicobacter test positive
  • urine red blood cells positive
  • urinary stones
  • hematuria
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urine
  • vulvar pruritus
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • cervical inflammation
  • vaginal discharge
  • dyslipidemia
  • hyperglycemia
  • hyponatremia
  • dermoid cysts
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • ocular discomfort
  • conjunctival injection
  • pathological myopia
  • retinal detachment
  • retinal deposits
  • retinal vein occlusion
  • traction retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • moist cough
  • allergic rhinitis
  • residual phlegm
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina pectoris
  • palpitations
  • Prinzmetal's angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • insomnia
  • otalgia
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • vulvar pruritus
  • genital pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the drug's effectiveness for a longer time.

Appearance and packaging

Appearance

White film-coated tablets that are oval and biconvex with a pink hue

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.